Skip to content
healthcare.dev

METHOTREXATE

NDC 46708-730, METHOTREXATE, tablet, from Alembic Pharmaceuticals Limited.

Product NDC
46708-730
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217552
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE SODIUM2.5 mg/1

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
46708-730-3146708073031100 TABLET in 1 BOTTLE (46708-730-31)
46708-730-364670807303636 TABLET in 1 BOTTLE (46708-730-36)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ff55c573-dc84-4ff3-9d10-2b24c47dd679

Use it

Look up 46708-730 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-730 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-730. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.